BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, April 28, 2026
Home » Topics » Briefs » Regulatory actions

Regulatory actions
Regulatory actions RSS Feed RSS

Regulatory actions for Nov. 18, 2025

Nov. 18, 2025
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Arcutis, Ascelia, Biogen, Bioinvent, Henlius, Incyte, Medicus, Obi, Organon, Sarepta, Silo, T-knife.
Read More

Regulatory actions for Nov. 18, 2025

Nov. 18, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Arctx, Bot Image, Hubly Surgical, Icecure, Levitas, Piccolo Medical, Quantalx.
Read More

Regulatory actions for Nov. 18, 2025

Nov. 18, 2025
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Biogen, H. Lundbeck, Ionis, Kura.
Read More

Regulatory actions for Nov. 17, 2025

Nov. 17, 2025
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Biogen, Cosmo, Eisai, Fondazione Telethon, H. Lundbeck, Ingenus, Ionis, Kura, Kyowa Kirin, Otsuka, Sanofi.
Read More

Regulatory actions for Nov. 17, 2025

Nov. 17, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Onward Medical.
Read More

Regulatory actions for Nov. 14, 2025

Nov. 14, 2025
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: ITM, Outlook.
Read More

Regulatory actions for Nov. 14, 2025

Nov. 14, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: .Rapid Nexus, Singleron, Zimmer Biomet.
Read More

Regulatory actions for Nov. 13, 2025

Nov. 13, 2025
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Marius, Parabilis.
Read More

Regulatory actions for Nov. 13, 2025

Nov. 13, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Brainsway, Hubly, Icotec, Vita, Withings.
Read More

Regulatory actions for Nov. 12, 2025

Nov. 12, 2025
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: March, Purdue.
Read More
Previous 1 2 … 14 15 16 17 18 19 20 21 22 … 336 337 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 27, 2026.
  • Illustration of a tumor

    Detecting the invisible: minimal residual disease at AACR 2026

    BioWorld Science
    Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists

    BioWorld Science
    Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
  • Glowing neural network inside a transparent capsule surrounded by a large language model

    Pharma industry faces long haul to get return on investment from AI

    BioWorld Science
    Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing